Medical NewsCDSCO Panel Directs Intas Pharma to Revise Phase I/III Pembrolizumab Trial Protocol DRRA3 months ago01 mins CDSCO Panel Directs Intas Pharma to Revise Phase I/III Pembrolizumab Trial Protocol We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link Post navigation Previous: Oral liquid dosage forms: Emerging trends and key challengesNext: Rajasthan Drug Official Under Probe for Misreporting Spurious Medicines Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.